Transparency Market Research

Global Meningococcal Vaccines Market to Be Worth US$3.7 Billion by 2019

Transparency Market Research Report Added "Meningococcal Vaccines Market" to its database.


Albany, NY -- (SBWIRE) -- 02/24/2015 -- Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research, a U.S. based market intelligence firm has added the report, titled "Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", to its research reports repository. The report states that the global meningococcal vaccines market has the potential of growing at a CAGR of 14.9% during 2013 and 2019. Growing at this pace, this market that valued US$1.5 billion in 2012 could achieve a net worth of US$3.7 billion by 2019.

Browse the full report at

Various strains of meningococcal bacteria cause serious infection to the thin lining surrounding the brain and spinal cord. The infection results in severe brain damage and can be fatal in 50% cases if left untreated. The high fatality rate of meningococcal disease is generally considered as a medical emergency. This is why, federal governments of various countries are actively involved in efforts for spreading awareness about the severity of the condition. Many government bodies are also involved in the research, development, and also the distribution of meningococcal vaccines regionally.

Transparency Market Research's report on the global meningococcal vaccines market presents an all-inclusive overview of the market and its various segments.

The report mainly focuses on major market segments based on the types of vaccines available in the meningococcal vaccine market, such as Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, and the vaccines in pipeline. The product types are further segmented according to the brands that feature them. An overview of geographically specific active regional markets is also included in the report.
Conjugates are expected to lead the global meningococcal vaccines market in the future. By observing growth at a CAGR of 12.9%, this product segment could amass net worth of nearly US$2.5 billion by 2019. Amongst the various meningococcal vaccines in pipeline currently, Novartis's Bexsero is expected to gain market shares at the fastest pace, an expected 24.7%, during the forecast period.

We are currently offering a flat 15% discount on all purchases until end of the March 2015!

The Department of Health, UK, states that Baxsero will be the first vaccine for serogroup B in the meningococcal vaccines market after its launch in the second quarter of 2014. Pfizer's MnB rLP2086 is another potential future vaccine that is currently in its third phase of trial. The launch of this vaccine, which has received a Breakthrough Therapy status from the U.S. FDA, is expected to change the complete outlook of this market by intensifying competition.

Geographically, North America was the leading shareholder of the global meningococcal vaccines market in 2011 due to government led immunization programs and favorable research and development initiatives undertaken by major drug companies in this region. Also, every year nearly 1,000 to 2,600 people in the U.S. contract meningitis from various strains of the bacteria. However, vaccines for only the serotypes A, C, Y, and W-135 are available in the U.S. market.

Regional market of Asia Pacific is expected to grow at the fastest pace in the global meningococcal vaccines market, at an estimated CAGR of 17.1%, by the end of 2019. Major drivers of growth in these regional markets are the low manufacturing cost of vaccines, and transfer of novel manufacturing technologies from developed countries to these regions.

Browse Full Press Release @

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Browse The Market Research Blog :